🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this episode of Inside the ProActive Study, Professor Ondrej Viklicky describes his publication findings correlating Prospera results with MMDX, such as otherwise undetected TCMR cases. Watch the full discussion here: ow.ly/spXn50VrHff #Natera #KidneyHealth

"And all of a sudden, with no additional invasive action, I have more knowledge, I have data, that can prevent my son from needing a biopsy." –JoDee on using Prospera to help inform her son's care post-transplant ow.ly/CiR250Vucb3 #Natera #DonateLife

Thank you to Natera Organ Health for their generous support! Partners like Natera make the #ISHLT2025 Annual Meeting possible. See Natera on-site in Boston at booth 401.

ICYMI: Rebroadcast Webinar from CEOT 2025 📈 Join us to review case studies where Prospera cfDNA provided a lead time indication of rejection, prior to being seen on biopsy. Register today: ow.ly/qMQ650VsMEa

Celebrate #KidsTransplantWeek & #NPTW with Transplant Families & sponsor @nateragenetics! 🎉 Join the 2025 Pediatric Transplant Conference on Fri, April 25th (10 AM-5:30 PM EDT) to learn how to help pediatric recipients THRIVE ! Register: transplantfamilies.org/ptc2025 #PTC2025 #Natera

We're looking forward to seeing you at #ISHLT2025! Learn about our 10 abstracts, join our symposia on dd-cfDNA innovations in heart and lung transplantation, and stop by booth # 401 to connect! 📈🤝 ow.ly/H6n350VyYFi The ISHLT #TransplantCare #HeartLung #ddcfDNA #Natera

Being APOL1 aware means knowing how your genes impact your kidney health. Knowing whether you have the APOL1 variants that cause AMKD could keep your kidneys working longer. The only way to know is to have a genetic test. American Kidney Fund #AMKDAwarenessDay ow.ly/3KZN50VjwbK

🔬 This Lab Week, we’re celebrating the dedicated teams from laboratory operations across Natera. Our lab teams are the heart of Natera, never losing sight that there’s a person behind each sample. Because of their work, we were able to serve more than 2 million patients last

Thank you, transplant nurses, for all that you do for the transplant community! #TransplantNurseWeek #Natera

Still feeling inspired by Scot Pollard, heart transplant recipient and NBA champion, who gave a powerful speech at #ISHLT2025. We are always in awe of the resilience of those in the transplant community. #Natera #TransplantInnovation The ISHLT

Identifying the genetic cause of kidney disease can offer critical insights: it informs prognosis, guides treatment options, and enables appropriate family screening. kidneyfund.org/amkd-awareness… #APOL1Aware #KidneyHealth #GeneticTesting

Exciting results from the DEFINE-HT study: Prospera Heart with donor quantity score (DQS) significantly correlates with clinical outcomes after heart transplantation and outperforms biopsy in predicting graft dysfunction. The prospective, multicenter DEFINE-HT study—the first

We’re also presenting how integrating real-world data with renal genetic test results reveals chronic kidney disease and treatment journeys in patients with autosomal dominant Alport syndrome. #ISPORAnnual #RenalGenetics

Join our webinar, Implementing Prospera - Advantages of our Natera Concierge Program, to learn more about: • Common questions when switching brands or starting a new workflow • Resources Natera can provide to your team • Our Natera Concierge Team 👉ow.ly/CqKl50VY2Yy

It’s a time to celebrate life, share hope, and recognize the incredible strength of those living with and beyond cancer. Whether you’re reflecting on your own survivorship or standing beside a loved one, today is about connection, resilience, and community. At Natera, we’re

Today, we celebrate fathers and father figures in all their forms. From guiding hands to quiet support, from hard-earned wisdom to unconditional encouragement, fatherhood shows up in countless ways. Some are dads by biology, others by choice. All leave a lasting impact. To the

❤️ One year of progress ❤️ One year of partnership ❤️ One year of Prospera Heart with DQS Learn more: ow.ly/8MOP50Wb3pu

🌎 Natera’s 2024 Sustainability Report is now live! This report reflects the efforts of teams across Natera to help reduce environmental impact, support our communities and foster a culture of belonging, while expanding access to our technology for more patients than ever before.

Check out this #ISHLTVoices podcast episode, presented by Natera Organ Health, on the evolution of #ddcfDNA testing and noninvasive rejection monitoring post-#HeartTransplantation. 🫀 🎧 LISTEN NOW at 🔗 bit.ly/4lnW9K2, Spotify, Apple Podcasts 🎧 #DQS #ProsperaHeart

👉 Check out the recording of Natera Organ Health's #ISHLT2025 industry symposium to learn more about dd-cfDNA in #LungTx rejection monitoring + how elevated #ProsperaLung tests may lead to important clinical insights for complex patients. 🫁💡📽️ 🔗: ishlt.org/about/news-det…